U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279506) titled 'Clinical Investigation of IXIUM TWIN Viscoelastic Ophthalmic Device For Cataract Surgery' on Nov. 24.
Brief Summary: This clinical trial is testing a new surgical gel called IXIUM TWIN, designed to protect the eye during cataract surgery. Cataracts, which cloud the eye's natural lens, are the leading cause of vision loss worldwide. Surgery to remove the cataract and replace it with an artificial lens is the standard treatment, and viscoelastic gels like IXIUM TWIN are used to keep the eye stable and safe during the procedure.
The goal of this study is to compare IXIUM TWIN with an already approved gel (HEALON) to ensure it works ju...